Decision Resources offers the industry’s leading epidemiology and market forecasts for the world’s most significant diseases.
Epidemiology
Decision Resources’ syndicated and custom epidemiology analyses quantify the relative burden of disease in major pharmaceutical and emerging markets. Our estimates provide the starting point for experienced analysts to model their own markets. The country-specific data we include in our analyses are recognized as the premier epidemiology in the industry.
Our epidemiology information includes:
- Prevalent and/or incident populations
- Diagnosed percentage and population
- Drug-treated percentage and population
- Country
- Gender
- Age
- Comorbidity
- Relevant disease subpopulations, including severity, lab measure, discharge diagnosis, time to presentation, seasonality and subtype
- Forecasts of prevalent or incident populations based on expected changes in demographics and risk factors
The following product lines include our comprehensive epidemiological analyses:
Custom epidemiological analyses
Our epidemiology group integrates their expertise and proven epidemiological methods with our consulting group’s knowledge and skill to provide your company with a custom analysis that is tailored to your business needs. Our epidemiology team can provide custom analyses for the world’s commonly occurring diseases as well as for rare, orphan, or difficult-to-study diseases. We have experience working on custom analyses in the major pharmaceutical as well as emerging markets.
Market Forecasts
The backbone of our Pharmacor reports, market forecasts drive the decision-making of our pharmaceutical, biotechnology and financial clients. With 5- and 10-year forecasts (in some cases, 15-year), our reports predict the success or failure of current and emerging drugs.
Each Pharmacor report comes with the Interactive Forecast Tool, which is a Microsoft Excel spreadsheet used to build a seven-country market forecast based on Decision Resources' patient-based market models. This file contains Decision Resources' market forecast data, tables and conclusions. Clients have the option to add as many as ten additional entries for interactive, custom market forecasts. This application permits detailed "what-if" analyses of Decision Resources' patient-based five- and ten-year forecasts.
The following product lines include market forecasts:
- The Interactive Forecast Tool — Pharmacor’s premier forecasting data set
The following product lines include information to assist with planning a market forecast: